Biomarkers of malnutrition in liver cirrhosis

Nutrition, Diet Therapy, and the Liver

Volumn , Issue , 2009, Pages 203-215

  Suzuki, Kazuyuki ^a   Takikawa, Yasuhiro ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862253059     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (60)

1. Assy, N., Z. Hochberg, R. Enat, et al. 1998. Prognostic value of generation of growth hormone-stimulated insulin-like growth factor-1 (IGF-1) and its binding protein-3 in patients with compensated and decompensated liver cirrhosis. Dig Dis Sci 43:1317-1321.
2. Atalay, B. G., C. Yagmur, T. Z. Nursal, et al. 2008. Use of subjective global assessment and clinical outcomes in critically ill geriatric patients receiving nutrition support. JPEN J Parenter Enteral Nutr 32:454-459.
3. Azuma, Y., M. Maekawa, Y. Kuwabara, et al. 1989. Determination of branched-chain amino acid and tyrosine in serum of patients with various hepatic diseases and its clinical usefulness. Clin Chem 35:1399-1403.
4. Bahr, M. J., K. H. Boeker, M. P. Manns, et al. 2008. Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but not associated with insulin resistance in patients with liver cirrhosis. Clin Endocrinol (Oxf) 68:1-22. http://www.blackwellsynergy.com/loi/cen.pdf.
5. Bahr, M. J., J. Ockenga, K. H. W. Boker, et al. 2006. Elevated resistin levels in cirrhosis are associated but not with insulin resistance. Am J Physiol Endocrinol Metab 29:E199-E206.
6. Brose, L. 1990. Prealbumin as a marker of nutritional status. J Burn Care Rehab 11:372-375.
7. Cabre, E., and M. A. Gassull. 2005. Nutrition in liver cirrhosis. Curr Opin Clin Nutr Metab Care 8:545-551.
8. Calamita, A., I. Dichi, S. J. Papini-Berto, et al. 1997. Plasma levels of transthyretin and retinolbinding protein in Child-A cirrhotic patients in relation to protein-calorie status and plasma amino acids, zinc, vitamin A and plasma thyroid hormones. Arq Gastroenterol34:139-147.
9. Campillo, B., J. P. Richardet, E. Scherman, et al. 2003. Evaluation of nutritional practice in hospitalized cirrhotic patients: Results of a prospective study. Nutrition 19:515-521.
10. Campillo, B., E. Sherman, J. P. Richardet, et al. 2001. Serum leptin levels in alcoholic liver cirrhosis: Relationship with gender, nutritional status, liver function and energy metabolism. Eur J Clin Nutr 55:980-988.
11. Caregaro, L., F. Alberino, P. Amodio, et al. 1996. Malnutrition in alcoholic and virus-related cirrhosis. Am J Clin Nutr 63:602-609.
12. Cummings, D. E., D. S. Weigle, S. Frayo, et al. 2003. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. New Engl J Med 346:1623-1630.
13. Devakonda, A., L. George, S. Raoof, et al. 2008. Transthyretin as a marker to predict outcome in critically ill patients. Clin Biochem 41:1126-1130.
14. Din, X., N. K. Saxena, S. Lin, et al. 2005. The role of leptin and adiponectin: A novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology. Am J Pathol166:1655-1699.
15. Fischer, J. E., H. M. Rosen, A. M. Ebeid, et al. 1976. The effect of normalization of plasma amino acids on hepatic encephalopathy. Surgery 80:77-91.
16. Fukushima, H., Y. Miwa, M. Shiraki, et al. 2007. Oral branched-chain amino acid supplementation improves the oxidized/reduced albumin ratio in patients with liver cirrhosis. Hepatol Res 37:765-70.
17. Gabay, C., and I. Kushner. 1999. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448-454.
18. Graham, T. E., Q. Yang, M. Bluher, et al. 2006. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 354:2552-2563.
19. Guglielmi, F. W., C. P. Panella, A. Buda, et al. 2005. Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism. Multicenter prospective study by the ‘Nutritional Problems in Gastroenterology’ Section of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis 37:681-688.
20. Hara, K., M. Horikoshi, T. Yamauchi, et al. 2006. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 29:1357-1362.
21. Johnson, A. M. 1999. Low levels of plasma proteins malnutrition or inflammation? Clin Chem Lab Med 37:91-96.
22. Jonsson, J. R., A. R. Moschen, I. J. Hickman, et al. 2005. Adiponectin and its receptors in patients with chronic hepatitis C. J Hepatol 43:929-936.
23. Kadowaki, T., and T. Yamauchi. 2005. Adiponectin and adiponectin receptors. Endocr Rev26:439-451.
24. Kakizaki, S., N. Sohara, Y. Yamazaki, et al. 2008. Elevated plasma resistin concentrations in patients with liver cirrhosis. J Gastroenterol Hepatol 23:73-77.
25. Kalaitzakis, E., I. Bosaeus, L. Ohman, et al. 2007. Altered postprandial glucose, insulin, leptin, and ghrelin in liver cirrhosis: Correlations with energy intake and resting energy expenditure. Am J Clin Nutr 85:808-815.
26. Kalender, B., B. Mutlu, M. Ersoz, et al. 2002. The effects of acute phase proteins on serum albumin, transferrin and haemoglobin in haemodyalysis patients. Int J Clin Pract 56:505-508.
27. Kawakami, A., K. Kubota, N. Yamada, et al. 2006. Identification and characterization of oxidized human serum albumin. A slight structural change impairs its ligand-binding and anti-oxidant functions. FEBS J 273:3346-3357.
28. Kojima, M., H. Hosoda, Y. Date, et al. 1999. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660.
29. Liu, C. J., P. J. Chen, Y. M. Jeng, et al. 2005. Serum adiponectin correlates with viral characteristics but not histological features in patients with chronic hepatitis C. J Hepatol 43:235-242.
30. Madden, A. M., and M. Y. Morgan. 1999. Resting energy expenditure should be measured in patients with cirrhosis, not predict. Hepatology 30:655-664.
31. Marchesini, G., N. Villanova, G. Bianchi, et al. 2004. Plasma ghrelin concentrations, food intake, and anorexia in liver disease. J Clin Endocrinol Metab 89:2136-2141.
32. McCullough, A. J., E. Bugianesi, G. Marchesini, et al. 1998. Gender-dependent alterations in serum leptin in alcoholic cirrhosis. Gastroenterology 115:947-953.
33. Morgan, M. Y., and K. W. Heaton. 2008. Nutrition, the liver, and gallstones. 2000. In Human Nutrition and Dietetics, ed. J. S. Garrow, W. P. T. Janes, and A. Ralph. London: Churchill Livingstone, pp. 575-603.
34. Morgan, M. Y., J. P. Milsom, and S. Sherlock. 1978. Plasma ratio of valine, leucine and isoleucine to phenylalanine and tyrosine in liver disease. Gut 19:1068-1073.
35. Moriwaki, H., Y. Miwa, M. Tajika, et al. 2004. Branched-chain amino acids as a protein- and energy-source in liver cirrhosis. Biochem Biophys Res Commun 313:405-409.
36. Moriya, K., K. Nakagawa, T. Santa, et al. 2001. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res 61:4365-4370.
37. Nakazato, M., N. Murakami, Y. Date, et al. 2001. A role of ghrelin in the central regulation of feeding. Nature 409:194-198.
38. Nwokolo, C. U., D. A. Freshwater, P. O’Hare, et al. 2003. Plasma ghrelin following cure of Helicobacter pylori. Gut 52:637-640.
39. Onodera, K., A. Kato, and K. Suzuki. 2001. Serum leptin concentrations in liver cirrhosis: Relationship to the severity of liver dysfunction and their characteristic diurnal profiles. Hepatol Res 21:205-212.
40. Peng, S., L. D. Plank, J. L. McCall, et al. 2007. Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: A comprehensive study. Am J Clin Nutr 85:1257-1266.
41. Petit, J. M., A. Minello, V. Jooste, et al. 2005. Decreased plasma adiponectin concentrations are closely related to steatosis in hepatitis C virus-infected patients. J Clin Endocrinol Metab 90:2240-2243.
42. Pugh, R. N. H., I. M. Murray-Lyon, J. L. Dawson, et al. 1973. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646-649.
43. Quinlan, G. J., G. S. Martin, and T. W. Evans. 2005. Albumin: Biochemical properties and therapeutic potential. Hepatology 41:1211-1219.
44. Riggio, O., S. Angeloni, L. Ciuffa, et al. 2003. Malnutrition is not related to alterations in energy balance in patients with stable liver cirrhosis. Clin Nutr 22:553-559.
45. Roongpisuthipong, C., A. Sobhonslidsuk, K. Nantiruj, et al. 2001. Nutritional assessment in various stages of liver cirrhosis. Nutrition 17:761-765.
46. Schere, P. E., S. Williams, M. Fogliano, et al. 1995. Novel serum protein similar to Clq produced exclusively in adipocytes. J Biol Chem 270:26746-26749.
47. Sohara, N., H. Takagi, S. Kakizaki, et al. 2004. Elevated plasma adiponectin concentrations in patients with liver cirrhosis correlate with plasma insulin levels. Liver Int 25:28-32.
48. Suzuki, K., A. Kato, and M. Iwai. 2004. Branched-chain amino acid treatment in patients with liver cirrhosis. Hepatol Res 30S:S25-S29.
49. Suzuki, T., K. Suzuki, K. Koizumi, et al. 2008. Measurement of serum branched-chain amino acid to tyrosine ratio level is useful in a prediction of a change of serum albumin level in chronic liver disease. Hepatol Res 38:267-272.
50. Tacke, F., G. Brabant, E. Kruck, et al. 2003. Ghrelin in chronic liver disease. J Hepatol38:447-454.
51. Tajika, M., M. Kato, H. Mohri, et al. 2002. Prognostic value of energy metabolism in patients with viral liver cirrhosis. Nutrition 18:229-234.
52. Takahashi, T., A. Kato, K. Onodera, et al. 2006. Fasting plasma ghrelin levels reflect malnutrition state in patients with liver cirrhosis. Hepatol Res 24:117-123.
53. Tietge, U. J., K. H. Boker, M. P. Manns, et al. 2004. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics. Am J Physiol Endocrinol Metab 287:E82-E89.
54. Tsiaousi, I. E., A. I. Hatzitolios, S. K. Trygonis, et al. 2008. Malnutrition in end stage liver disease: Recommendations and nutritional support. J Gastroenterol Hepatol 23:527-533.
55. Wang, Z. V., and P. E. Scherer. 2007. Adiponectin, cardiovascular function, and hypertension. Hypertension 51:8-14.
56. Watanabe, A., S. Mastuzaki, H. Moriwaki, et al. 2004. Problem in serum albumin measurement and clinical significance of albumin microheterogeneity in cirrhosis. Nutrition20:351-357.
57. Weigle, D. S., T. R. Bukowski, D. C. Foster, et al. 1995. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J Clin Invest 96:2065-2070.
58. Yagmur, E., R. Weiskirchen, A. M. Gressner, et al. 2007. Insulin resistance in liver cirrhosis is not associated with circulating retinol-binding protein 4. Diabetes Care 30:1168-1172.
59. Yang, Q., T. E. Graham, N. Mody, et al. 2005. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436:356-362.
60. Zhang, Y., R. Procnca, M. Maffei, et al. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432.